This study is to determine the safety and efficacy of a possible treatment (NBI-98854) in children with Tourette Syndrome. We invite children who have a diagnosis of Tourette Syndrome to determine if they qualify for this study.Each participant will be evaluated to determine his or her eligibility to participate in the clinical research study. Each person who qualifies will receive:
• A placebo-controlled investigational treatment.
• Study-related medical exams and study-related laboratory tests at no cost.
• Compensation for time and travel.
About Tourette Syndrome (TS)
Tourette syndrome (TS) is a condition that includes repetitive, involuntary sounds and movements called tics. It is a neurological condition that can affect children, adolescents, and adults. Generally, the symptoms first appear in childhood and improve in the later teen years, but in some cases they can continue into adulthood.
The estimates of the number of people in the US affected by Tourette syndrome vary widely, but several studies show that as many as 1% of children ages 5-18 are affected by TS. The tics associated with Tourette syndrome can change over time and vary in severity. Also, TS is often associated with other conditions, including Attention Deficit/Hyperactivity Disorder, Obsessive-Compulsive Disorder, and anxiety.
Interested in participating? Please fill out the following form and we will contact you.